Plas D R, Williams C B, Kersh G J, White L S, White J M, Paust S, Ulyanova T, Allen P M, Thomas M L
Howard Hughes Medical Institute, and Center for Immunology, Department of Pathology, Washington University, St. Louis, MO 63110, USA.
J Immunol. 1999 May 15;162(10):5680-4.
The binding kinetics of the TCR for its interacting ligand and the nature of the resulting signal transduction event determine the fate of a developing thymocyte. The intracellular tyrosine phosphatase SHP-1 is a potential regulator of the TCR signal transduction cascade and may affect thymocyte development. To assess the role of SHP-1 in thymocyte development, we generated T cell-transgenic mice that express a putative dominant negative form of SHP-1, in which a critical cysteine is mutated to serine (SHP-1 C453S). SHP-1 C453S mice that express the 3.L2 TCR transgene are increased in CD4 single positive cells in the thymus and are increased in cells that express the clonotypic TCR. These data suggest that the expression of SHP-1 C453S results in increased positive selection in 3.L2 TCR-transgenic mice and support a role for SHP-1 thymocyte development.
TCR与其相互作用配体的结合动力学以及由此产生的信号转导事件的性质决定了发育中的胸腺细胞的命运。细胞内酪氨酸磷酸酶SHP-1是TCR信号转导级联反应的潜在调节因子,可能影响胸腺细胞的发育。为了评估SHP-1在胸腺细胞发育中的作用,我们构建了表达一种假定的SHP-1显性负性形式的T细胞转基因小鼠,其中一个关键的半胱氨酸被突变为丝氨酸(SHP-1 C453S)。表达3.L2 TCR转基因的SHP-1 C453S小鼠胸腺中的CD4单阳性细胞增加,表达克隆型TCR的细胞也增加。这些数据表明,SHP-1 C453S的表达导致3.L2 TCR转基因小鼠的阳性选择增加,并支持SHP-1在胸腺细胞发育中的作用。